Kazia Therapeutics
KZIA
11 hedge funds and large institutions have $1.24M invested in Kazia Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
57% less capital invested
Capital invested by funds: $2.9M → $1.24M (-$1.66M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$152K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$140K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$564K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |
| 3 |
SG Americas Securities
New York
|
-$60.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$23.9K |
| 5 |
Citigroup
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $846K | -$564K | -1,836 | -31% |
|
2
Envestnet Asset Management
Chicago,
Illinois
| $111K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $104K | +$152K | +495 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $95K | +$140K | +455 | New |
|
|
5
SG Americas Securities
New York
| $59K | -$60.8K | -198 | -41% |
|
|
6
UBS Group
Zurich,
Switzerland
| $10K | +$15K | +49 | New |
|
|
7
Simplex Trading
Chicago,
Illinois
| $4K | -$23.9K | -78 | -80% |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $1K | -$1.84K | -6 | -60% |
|
|
CFN
10
Cordasco Financial Network
Naples,
Florida
| $1K | – | – | – |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$192K | -501 | Closed |
|
|
12
Citigroup
New York
| – | -$5K | -12 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$1K | -2 | Closed |
|
KZIA Hedge Fund Activity: Q2 2022 in Review
11 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2022, worth a combined $1.24M — down 57% from $2.9M a quarter earlier.
Fund positioning in KZIA was balanced in Q2 2022: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 4 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $152K. The largest seller was Morgan Stanley, cutting an estimated $564K.
- 11 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.24M of Kazia Therapeutics stock for Q2 2022, down 57% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q2 2022 and 3 closed out, a net change of 0 holders.
- The largest Kazia Therapeutics buyer in Q2 2022 was Two Sigma Securities, an estimated $152K added.
- The largest Kazia Therapeutics seller in Q2 2022 was Morgan Stanley, an estimated $564K sold.
Based on aggregated 13F filings for Q2 2022.